JUN and ovarian carcinoma: In addition, since IL-13/IL-13Rα2 axis is involved in AP-1 signal transduction pathway in human GBM similar to pancreatic and ovarian cancer (Fig. 6), we believe that specific targeting of this pathway may be an important target for therapeutic intervention for GBM therapy.